The healthcare commercial intelligence company went public Wednesday on the Nasdaq exchange offering 15.6 million shares priced at $27 a share. The Framingham, Massachusetts-based company had previously filed to offer the same number of shares at a range of $21 to $24. The stock is listed on the Nasdaq exchange under the ticker symbol “DH.”